Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study. - Zhai, Tianyue; Mitamura, Takashi; Wang, Lei; Kubota, Shimpei I.; Murakami, Masaaki; Tanaka, Shinya; Watari, Hidemichi (Cancer Medicine, 2023)